Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Lucid Group

Peloton

Investors will always continue to chase weak stocks that are poorly rated for the chance at contrarian success. Yet, most times it is best to follow the herd when Wall Street repeatedly raises the warning flag on a given stock.

Red Alert! 3 Nasdaq Stocks Wall Street Is Warning Investors About.

Canopy Growth (NASDAQ: CGC ) is looking like a key beneficiary amid rising calls for federal marijuana policy reform. As of this writing, CGC stock has gained more than 10% on Wednesday.

Why Does Canopy Growth (CGC) Stock Keep Climbing This Week?

Canopy Growth stock led weed stocks higher early Wednesday. Shares continue rallying on Vice President Kamala Harris' call to reclassify marijuana.

Canopy Growth Stock Spikes, Weed Stocks Still Trade Higher Days After VP Harris Comments

Tilray Brands

Village Farms International

As we turn our attention to the Canadian cannabis sector and top marijuana stocks this week, it's hard not to notice the buzz it's creating among investors. With Canada leading the charge in legalizing cannabis for both medical and recreational use, its companies are now at the heart of a growing global market. This makes Canadian cannabis stocks particularly interesting to watch. They're not just a reflection of the thriving market at home; they symbolize Canada's prominent role on the world stage. The excitement is palpable as investors keep their eyes peeled for signs of growth and strategic international moves. Keeping up with market trends, regulatory shifts, and the competitive landscape is key to staying ahead.

Canadian Cannabis Stocks to Watch in Mid-March 2024

Scotts Miracle-Gro

While it's difficult to say with confidence who will win out in the elections later this year, investors of cannabis stocks may have something to look forward to. Basically, the attention should turn not to a possible red or blue wave but rather a green one.

3 Cannabis Stocks Ready to Light Up on Reform Rumors

Aurora Cannabis

SNDL Inc.

Cannabis stocks surged Monday after Vice President Kamala Harris called on the Drug Enforcement Administration (DEA) to reschedule marijuana “as quickly as possible.” Cannabis is currently a Schedule 1 narcotic, the same classification as heroin, a point Harris called “absurd” and “patently unfair.

Why Are Cannabis Stocks TLRY, ACB, CGC, SNDL Up Today?

Vice President Kamala Harris wants the federal government to expedite its rescheduling of marijuana. Rescheduling would likely boost Canopy Growth's efforts to set up a U.S.-based holding company.

Why Canopy Growth Stock Is Flying High Today

Cronos Group

Cannabis stocks moved higher after US Vice President Kamala Harris on Friday urged the Drug Enforcement Administration (DEA) to reschedule marijuana as a lower-risk drug “as quickly as possible.” Harris, at a White House meeting with individuals who have received marijuana pardons from the Biden administration, said that it was “absurd” and “patently unfair” that marijuana remains in the same drug category as heroin and is considered more dangerous than fentanyl.

Cannabis stocks rally as VP Harris calls on DEA to reschedule marijuana ‘as quickly as possible'

Curaleaf Holdings, Inc.

It is a good Monday for Cannabis stocks. Canopy Growth (CGC), Curaleaf (CURLF),  and Aurora Cannabis (ACB) stock prices surged by more than 10% in the pre-market session.

Aurora Cannabis, Canopy Growth, Curaleaf stocks spiked: here's why

This week is shaping up to be an intriguing one for Canadian marijuana stocks, with several names catching the eyes of investors. As the industry forges ahead, these companies are emerging as ones to watch, thanks to their potential for growth and the dynamic nature of the market. Investors and traders seek solid earnings reports, strategic alliances, and opportunities to break into new markets. Given Canada's established cannabis landscape, these firms offer insights into the sector's continuous evolution, serving as a barometer for wider industry trends.

Top Canadian Cannabis Stocks 2024: Ultimate Investment Guide

Shareholders are encouraged to vote well in advance of the proxy voting deadline on April 10, 2024 at 1:00 p.m. Eastern Time (Toronto time) For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com.

INDEPENDENT PROXY ADVISOR, GLASS LEWIS, RECOMMENDS CANOPY GROWTH SHAREHOLDERS VOTE FOR THE CREATION OF EXCHANGEABLE SHARES TO FURTHER THE ADVANCEMENT OF CANOPY USA

SMITHS FALLS, ON , March 11, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced additional details with respect to the previously announced special resolution to be voted on by the shareholders of Canopy Growth (the "Canopy Shareholders") authorizing an amendment to the Company's articles of incorporation, as amended (the "Amendment Proposal"), in order to: (i) create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating exchangeable shares in the capital of Canopy Growth (the "Exchangeable Shares"); and (ii) restate the rights of the common shares in the capital of Canopy Growth (the "Common Shares") to provide for a conversion feature whereby each Common Share may at any time, at the option of the holder, be converted into one Exchangeable Share. Canopy Shareholders will be asked to consider and vote on the Amendment Proposal at a special meeting of Canopy Shareholders on Friday, April 12, 2024 at 1:00PM ET (the "Meeting").

CANOPY GROWTH ANNOUNCES DETAILS REGARDING CONVERTING INTO EXCHANGEABLE SHARES

Fisker Inc

MicroVision

New York Community Bancorp

Office Properties Income Trust

Plug Power

Virgin Galactic

So far this year, AI stocks are all the rage, and major indices like the S&P 500 are hitting new highs. However, things have been playing out differently in the world of penny stocks.

It's Time! 7 Pitiful Penny Stocks to Sell Right Now

OrganiGram Holdings Inc.

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at Jefferies believe.  They have a ‘Buy' rating on Organigram, which they said remains a top Canadian cannabis pick, writing in a note to clients that Organigram's first quarter 2024 earnings showed progress on every metric.

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts

People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.

3 Canadian Marijuana Stocks To Start The New Week

This week, the spotlight shines on Canadian cannabis stocks, marking an intriguing phase for investors and market watchers. Companies like Canopy Growth, Aurora Cannabis, and Tilray have become household names. They navigate the complex landscape of legal cannabis markets. Recent shifts in regulatory frameworks and market dynamics play a crucial role. These companies are on the brink of their quarterly earnings reports. This period could reveal significant insights into their operational efficiencies and market demand.

Investor Alert: Top Canadian Cannabis Picks for March 2024

SMITHS FALLS, ON , Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway. "Forging ahead with our commitment to innovation, we're excited to offer new pre-roll offerings that meet consumers across a range of occasions and price points," said Dave Paterson, President, Canada, Canopy Growth.

CANOPY GROWTH LAUNCHES NEW PRE-ROLLS FROM 7ACRES AND HIWAY

Aurora Cannabis and Canopy Growth shares have fallen more than 99% in just five years. Both companies have been scaling back their operations and remain unprofitable.

2 Hugely Disappointing Stocks That Turned $10,000 Into Less Than $100 in Just 5 Years

Shareholders to vote on the creation of a new class of Exchangeable Shares, which is expected to be a critical step in strategy to accelerate Canopy Growth's entry into the over $50B 1 U.S. THC market. For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com.

CANOPY GROWTH TO HOLD SPECIAL MEETING OF SHAREHOLDERS

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF's year-to-date performance has been the increased popularity of high-beta securities.

It's Time! 3 Overhyped Cannabis Stocks to Sell in February.

Canopy Growth's recent results show that the company has been making strides in improving its bottom line and decreasing cash burn. Top-line growth has been more difficult, given the company's divestment of BioSteel.

Do Canopy Growth's Improved Q3 Numbers Give Investors Hope for a Turnaround?

ARM Holdings PLC

Cadence Design Systems

Paramount Global

PepsiCo

Starbucks

The Nasdaq continues to lead the three major stock indices and is currently near its all-time high. In fact, year-to-date, the Nasdaq is up 5%.

Exit Now! 7 Nasdaq Stocks to Sell in February 2024.

The Canadian cannabis sector remains a hotbed of activity, drawing attention from investors globally. With legalization trends expanding, Canadian marijuana stocks are at the forefront. This week, several companies stand out due to their market movements and potential growth opportunities. Investors are keenly watching these stocks. They're looking for signs of strong financial health and strategic positioning. Overall, the global cannabis industry's expansion plays a crucial role in this interest.

Cannabis Market Movers: Canada's Top Picks for Mid-February 2024

MedMen Enterprises Inc.

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration mulls over changing marijuana's Schedule 1 status and the Health and Human Services leans towards relaxing federal restrictions, a sliver of hope emerges.

Exit Now! 3 Cannabis Stocks to Sell in February 2024

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) showcased signs of financial improvement despite reporting a net loss, driven by increased revenue from its Canadian cannabis business and plans to advance its Canopy USA strategy for entry into the U.S. market.

News for Canopy Growth Stock (CGC)